The Impact of Visceral Obesity on Chronic Constipation, Inflammation, Immune Function and Cognitive Function in Patients with Inflammatory Bowel Disease

Overview

Journal Aging (Albany NY)

Specialty Geriatrics

Date 2021 Mar 6

PMID 33675295

Citations 3

Authors

Yemin Wan

Dan Zhang

Ting Xing

Qiaoling Liu

Yumeng Chi

Huixiang Zhang

Haihua Qian

Affiliations

Soon will be listed here.

Abstract

Objective: Obesity has gained attention among patients with inflammatory bowel disease (IBD). The impact of visceral obesity on chronic constipation, inflammation, immune function and cognition after diagnosis of IBD is still unknown.

Methods: This is a cross-sectional study of 150 IBD patients. Patients' visceral adipose tissue (VAT) and subcutaneous adipose tissue (SAT) were measured and were grouped according to visceral obesity. The potential impact of visceral obesity on cognitive function were evaluated using Mini-Mental State Examination. We evaluated patients' incidence of chronic constipation, levels of interleukin-6 (IL-6), T cells and body mass index in two groups.

Results: The prevalence of visceral obesity was 51% (37 out of 72) for Crohn's disease (CD) patients and 26% for UC patients (20 out of 78 patients). CD patients with visceral obesity has higher incidence of chronic constipation (81% vs. 57%, = 0.028), higher IL-6 levels (15.28 pg/ml vs. 9.429 pg/ml, = 0.007) and lower CD4 T cells (32.7% vs. 44.0%, < 0.001). VAT/SAT ratio is associated with BMI ( < 0.001).

Conclusions: IBD patients had high risks of visceral obesity. CD Patients with visceral obesity had higher prevalence of chronic constipation, higher inflammation levels, decreased immune function.

Citing Articles

Naloxegol for the Treatment of Opioid-Induced Constipation in Patients with Cancer Pain: A Pooled Analysis of Real-World Data.

Sabate J, Beato-Zambrano C, Cobo M, Lemaire A, Montesarchio V, Serna-Montros J Cancers (Basel). 2025; 17(5).

PMID: 40075711 PMC: 11898930. DOI: 10.3390/cancers17050865.

BC99 Relieves Constipation Symptoms by Regulating Inflammatory, Neurotransmitter, and Lipid Metabolic Pathways: A Randomized, Double-Blind, Placebo-Controlled Trial.

Fan Q, Gao Y, Zhou Y, Wu J, Wang H, Dong Y Foods. 2025; 14(4).

PMID: 40002098 PMC: 11854163. DOI: 10.3390/foods14040654.

Association of the body roundness index with chronic diarrhea and chronic constipation: findings based on the National Health and Nutrition Examination Survey 2005-2010 data.

Wang Y, Chen F, Zhang B, Song Z Lipids Health Dis. 2025; 24(1):33.

PMID: 39891178 PMC: 11783814. DOI: 10.1186/s12944-025-02451-7.

Association between dietary calcium intake and constipation in a metabolic syndrome population: evidence from NHANES 2005-2010.

Zhu L, Yang L, Liang Z, Shi W, Ma M, Chen J Front Nutr. 2024; 11:1422564.

PMID: 39539369 PMC: 11557474. DOI: 10.3389/fnut.2024.1422564.

Reduces Lipopolysaccharide-Induced Inflammation in Caco-2 Cells and Ameliorates Loperamide-Induced Constipation in Mice.

Kirindage K, Jayasinghe A, Jang M, Lee K, Yun H, Ahn G J Microbiol Biotechnol. 2024; 34(12):2565-2575.

PMID: 39467690 PMC: 11729519. DOI: 10.4014/jmb.2407.07036.

References

Jung S, Saxena A, Kaur K, Fletcher E, Ponemone V, Nottingham J . The role of adipose tissue-associated macrophages and T lymphocytes in the pathogenesis of inflammatory bowel disease. Cytokine. 2012; 61(2):459-68. DOI: 10.1016/j.cyto.2012.11.021. View

Hsieh S, Kim S, Shim Y, Huang L, Yang Y . A comparison of sociobehavioral impact on cognitive preservation in Alzheimer's disease between Taiwan and Korea: A cross-national study. Medicine (Baltimore). 2020; 99(15):e19690. PMC: 7220150. DOI: 10.1097/MD.0000000000019690. View

Savas M, Wester V, Staufenbiel S, Koper J, van den Akker E, Visser J . Systematic Evaluation of Corticosteroid Use in Obese and Non-obese Individuals: A Multi-cohort Study. Int J Med Sci. 2017; 14(7):615-621. PMC: 5562111. DOI: 10.7150/ijms.19213. View

Nagata N, Sakamoto K, Arai T, Niikura R, Shimbo T, Shinozaki M . Effect of body mass index and intra-abdominal fat measured by computed tomography on the risk of bowel symptoms. PLoS One. 2015; 10(4):e0123993. PMC: 4408111. DOI: 10.1371/journal.pone.0123993. View

Pedditzi E, Peters R, Beckett N . The risk of overweight/obesity in mid-life and late life for the development of dementia: a systematic review and meta-analysis of longitudinal studies. Age Ageing. 2016; 45(1):14-21. DOI: 10.1093/ageing/afv151. View

Shi H, Wang Q, Zheng M, Hao S, Lum J, Chen X . Supplement of microbiota-accessible carbohydrates prevents neuroinflammation and cognitive decline by improving the gut microbiota-brain axis in diet-induced obese mice. J Neuroinflammation. 2020; 17(1):77. PMC: 7055120. DOI: 10.1186/s12974-020-01760-1. View

Maconi G, Ardizzone S, Cucino C, Bezzio C, Russo A, Porro G . Pre-illness changes in dietary habits and diet as a risk factor for inflammatory bowel disease: a case-control study. World J Gastroenterol. 2010; 16(34):4297-304. PMC: 2937110. DOI: 10.3748/wjg.v16.i34.4297. View

Chan S, Luben R, Olsen A, Tjonneland A, Kaaks R, Teucher B . Body mass index and the risk for Crohn's disease and ulcerative colitis: data from a European Prospective Cohort Study (The IBD in EPIC Study). Am J Gastroenterol. 2013; 108(4):575-82. DOI: 10.1038/ajg.2012.453. View

Bani Hassan E, Demontiero O, Vogrin S, Ng A, Duque G . Marrow Adipose Tissue in Older Men: Association with Visceral and Subcutaneous Fat, Bone Volume, Metabolism, and Inflammation. Calcif Tissue Int. 2018; 103(2):164-174. DOI: 10.1007/s00223-018-0412-6. View

10.

Causey M, Johnson E, Miller S, Martin M, Maykel J, Steele S . The impact of obesity on outcomes following major surgery for Crohn's disease: an American College of Surgeons National Surgical Quality Improvement Program assessment. Dis Colon Rectum. 2011; 54(12):1488-95. DOI: 10.1097/DCR.0b013e3182342ccb. View

11.

Mendall M, Gunasekera A, John B, Kumar D . Is obesity a risk factor for Crohn's disease?. Dig Dis Sci. 2011; 56(3):837-44. DOI: 10.1007/s10620-010-1541-6. View

12.

Sudo N, Chida Y, Aiba Y, Sonoda J, Oyama N, Yu X . Postnatal microbial colonization programs the hypothalamic-pituitary-adrenal system for stress response in mice. J Physiol. 2004; 558(Pt 1):263-75. PMC: 1664925. DOI: 10.1113/jphysiol.2004.063388. View

13.

Sato T, Kameyama T, Ohori T, Matsuki A, Inoue H . Effects of eicosapentaenoic acid treatment on epicardial and abdominal visceral adipose tissue volumes in patients with coronary artery disease. J Atheroscler Thromb. 2014; 21(10):1031-43. DOI: 10.5551/jat.23390. View

14.

Coelho M, Oliveira T, Fernandes R . Biochemistry of adipose tissue: an endocrine organ. Arch Med Sci. 2013; 9(2):191-200. PMC: 3648822. DOI: 10.5114/aoms.2013.33181. View

15.

Krane M, Allaix M, Zoccali M, Umanskiy K, Rubin M, Villa A . Does morbid obesity change outcomes after laparoscopic surgery for inflammatory bowel disease? Review of 626 consecutive cases. J Am Coll Surg. 2013; 216(5):986-96. DOI: 10.1016/j.jamcollsurg.2013.01.053. View

16.

Khalili H, Ananthakrishnan A, Konijeti G, Higuchi L, Fuchs C, Richter J . Measures of obesity and risk of Crohn's disease and ulcerative colitis. Inflamm Bowel Dis. 2015; 21(2):361-8. PMC: 4308549. DOI: 10.1097/MIB.0000000000000283. View

17.

Vitale S, Strisciuglio C, Pisapia L, Miele E, Barba P, Vitale A . Cytokine production profile in intestinal mucosa of paediatric inflammatory bowel disease. PLoS One. 2017; 12(8):e0182313. PMC: 5552230. DOI: 10.1371/journal.pone.0182313. View

18.

Nobrega V, Silva I, Brito B, Silva J, Silva M, Santana G . THE ONSET OF CLINICAL MANIFESTATIONS IN INFLAMMATORY BOWEL DISEASE PATIENTS. Arq Gastroenterol. 2018; 55(3):290-295. DOI: 10.1590/S0004-2803.201800000-73. View

19.

Jones G, McLoughlin R, Hammond V, Parker C, Williams J, Malhotra R . Loss of CD4+ T cell IL-6R expression during inflammation underlines a role for IL-6 trans signaling in the local maintenance of Th17 cells. J Immunol. 2010; 184(4):2130-9. DOI: 10.4049/jimmunol.0901528. View

20.

Atreya R, Neurath M . Involvement of IL-6 in the pathogenesis of inflammatory bowel disease and colon cancer. Clin Rev Allergy Immunol. 2005; 28(3):187-96. DOI: 10.1385/CRIAI:28:3:187. View